QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.74 (-1.02%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.37 (+0.29%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.26%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.74 (-1.02%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.37 (+0.29%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.26%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.74 (-1.02%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.37 (+0.29%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.26%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.74 (-1.02%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.37 (+0.29%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.26%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)

Ainos Stock Price, News & Analysis (NASDAQ:AIMD)

$0.60
+0.00 (+0.15%)
(As of 05:11 PM ET)
Compare
Today's Range
$0.60
$0.60
50-Day Range
$0.58
$0.69
52-Week Range
$0.50
$1.83
Volume
66,413 shs
Average Volume
349,087 shs
Market Capitalization
$12.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Ainos

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

AIMD Stock Price History

AIMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive AIMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
11/28/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/29/2024

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AIMD
Employees
43
Year Founded
N/A

Profitability

Net Income
$-14,010,000.00
Net Margins
-874.50%
Pretax Margin
-874.41%

Debt

Sales & Book Value

Annual Sales
$3.52 million
Book Value
$1.73 per share

Miscellaneous

Free Float
19,370,000
Market Cap
$12.15 million
Optionable
Not Optionable
Beta
1.32
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Chun-Hsien Tsai (Age 53)
    Chairman of Board, President & CEO
    Comp: $116.96k
  • Mr. Lawrence Kennedy Lin (Age 54)
    Executive Vice President of Operations
    Comp: $133.02k
  • Ms. Meng-Lin Sung
    Chief Financial Officer
  • Mr. John Junyong Lee Esq. (Age 56)
    Chief Legal Counsel, Corporate Counsel & Secretary
  • Mr. Chih-Heng Lu (Age 43)
    Director of Corporate Developoment














AIMD Stock Analysis - Frequently Asked Questions

How have AIMD shares performed in 2023?

Ainos' stock was trading at $0.66 at the beginning of the year. Since then, AIMD stock has decreased by 9.3% and is now trading at $0.5989.
View the best growth stocks for 2023 here
.

Are investors shorting Ainos?

Ainos saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 25,800 shares, a drop of 6.9% from the October 31st total of 27,700 shares. Based on an average daily trading volume, of 31,800 shares, the short-interest ratio is presently 0.8 days. Approximately 0.4% of the company's stock are short sold.
View Ainos' Short Interest
.

When is Ainos' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our AIMD earnings forecast
.

When did Ainos IPO?

(AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

How do I buy shares of Ainos?

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AIMD) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -